Test Price
2,800 AEDโ Home Collection Available
HARS2 Gene Perrault Syndrome Type 2 NGS Genetic Test in UAE โ DNA Labs UAE
Clinical Executive Summary & Core Metrics
Test Overview & Methodology
The HARS2 Gene NGS Test analyzes the HARS2 gene using next-generation sequencing (NGS) to detect pathogenic mutations associated with Perrault Syndrome Type 2, a rare autosomal recessive disorder characterized by sensorineural hearing loss and ovarian dysfunction. This highly accurate molecular diagnostic assay provides definitive genotyping to guide clinical management, genetic counseling, and family planning.
| Parameter | Our Test (NGS โ Next-Generation Sequencing) | Closest Alternative (Sanger Sequencing) |
|---|---|---|
| Precision / Method | Full gene coverage, detects known and novel variants; high-throughput NGS | Limited to preโdefined mutations; lower discovery power |
| Turnaround Time | 3 to 4 weeks | 4 to 6 weeks |
| Diagnostic Sensitivity | > 99.9% (ISO 9001:2015 certified) | ~95% for targeted regions |
Physician Insight & Safety Protocols
"As a Consultant Medical Geneticist, I emphasize that genetic testing for Perrault Syndrome Type 2 requires comprehensive pre- and post-test counseling. The HARS2 gene analysis via NGS offers high diagnostic yield, but results must be interpreted strictly within the clinical context. A negative result does not exclude a genetic etiology, and a positive result necessitates informed discussion regarding inheritance patterns and family screening."
โ Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA ID: 9294403
Medication & Clinical Advisory
โ ๏ธ Important Advisory: Do not discontinue prescribed medications or therapies without consulting your physician. Genetic test results are intended to support clinical decision-making and should not replace your current treatment plan without a multidisciplinary review.
Exclusion Criteria & Emergency Red Flags
- Active acute infection or febrile illness โ consider postponing non-urgent genetic testing.
- Inability to provide informed consent (minors require legal guardian consent per Federal Decree-Law No. 4 of 2016 on Medical Liability).
- If you experience sudden severe hearing loss, acute abdominal pain, or seizures, seek emergency care immediately โ this test is not a substitute for urgent medical evaluation.
- This test is not designed for prenatal diagnosis without prior genetic counselling.
Patient FAQ & Clinical Guidance
1. What is the HARS2 Gene Perrault Syndrome Type 2 NGS Test and why is it performed?
This next-generation sequencing test examines HARS2 gene mutations causing Perrault Syndrome Type 2, a condition involving hearing loss and ovarian dysfunction. It is used for accurate diagnosis, genetic counseling, and family planning.
2. How is the sample collected and what is the turnaround time?
A simple blood sample, extracted DNA, or a single drop on an FTA card is collected via our VIP Mobile Phlebotomy service at your home. Results are available within 3 to 4 weeks.
3. Is this genetic test covered by insurance in the UAE?
We offer direct billing verification via WhatsApp at +971 54 548 8731 to check your insurance coverage for genetic testing and assist with claim submissions.
UAE Regulatory & Data Privacy Adherence
DNA Labs UAE strictly adheres to:
- Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL).
- Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields.
- Federal Decree-Law No. 4 of 2016 on Medical Liability.
All genetic data remains strictly confidential. Results are securely released only to the authorized physician and the patient. Laboratory operations are certified to ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139).
Clinical & Logistical Metadata
| Test Name | HARS2 Gene NGS Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3 to 4 weeks |
| Sample Type / Matrix | Whole Blood, Extracted DNA, or FTA Card |
| Methodology Used | Next-Generation Sequencing (NGS) |
| ICD-10-CM Code | H90.5, Q87.8 |
| LOINC Code | 91703-3 |
| DHA Facility License & Address | DHA License No: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
ุฏุนู ุซูุงุฆู ุงููุบุฉ ู ุชุงุญ
ุงูุชุญูู ู ู ุงูุชุบุทูุฉ ุงูุชุฃู ูููุฉ
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
ุชููู ุนู ุงูุชุฎู ูู. ุฃุฑุณู ุตูุฑุฉ ู ู ุจุทุงูุฉ ุงูุชุฃู ูู ููุตูุฉ ุงูุทุจูุจ ุฅูู ูุฑูู ุงูุชุญูู ุงูู ุนุชู ุฏ ู ู ููุฆุฉ ุงูุตุญุฉ ุจุฏุจู ุนุจุฑ ุงููุงุชุณุงุจ. ุงุญุตู ุนูู ุชุญุฏูุซ ุงูุญุงูุฉ ูู ุฏูุงุฆู.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians